English press releases

Phase II trial results demonstrated improvement in cognition with BI 425809 in adult patients with schizophrenia

Results presented at the 33rd ECNP Congress from a 12-week, placebo-controlled Phase II trial demonstrated BI 425809 has met its primary endpoint1,2 Trial results, together...

H.I.G. Capital Acquires Rental Residential Portfolios in Dublin

LONDON–(BUSINESS WIRE)– H.I.G. Capital, LLC (“H.I.G.”), a leading global alternative investment firm with $40 billion of equity capital under management, announced today that one of...

 Vertex Announces European Medicines Agency Type II Variation Marketing Authorization Application Validation for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination with ivacaftor in People with One Copy of the F508del Mutation

LONDON–(BUSINESS WIRE)– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the European Medicines Agency (EMA) has validated a Type II Variation Marketing Authorization Application (MAA) for...

Public Wants Greater Focus on Science-Based Decision-Making Says New International Survey from Philip Morris International

Majority of adults surveyed believe science can solve critical global challenges. However, only half of respondents believe governments are doing a good job in leveraging...

Starpharma’s SPL7013 COVID-19 Nasal Spray Virucidal Against SARS-CoV-2

New data generated at Scripps Research Institute in the US shows that Starpharma’s antiviral nasal spray active (SPL7013) is virucidal, inactivating more than 99.9% of...

ZEDRA Announces Milestone Acquisition of Global Expansion Specialist Fitzgerald & Law.

LONDON–(BUSINESS WIRE)– ZEDRA, the fast growing global specialist in Corporate, Fund and Active Wealth Solutions has announced the acquisition of Fitzgerald & Law (F&L), London’s...

Ipsen Showcases Commitment to Patient-centric Advances in Oncology With Record Number of Abstracts to Be Presented at ESMO 2020 Virtual Congress

17 abstracts1 to be shared, spanning a wide range of different cancer types, therapies and clinical study and real-world evidence designs Presentations will feature promising...

Western Union steunt de ontheemden van het Moria-kamp

Fondsen van Western Union en Western Union Foundation ter ondersteuning van onmiddellijke hulpverlening gericht op de meest urgente behoeften van ontheemde Moria-bewoners DENVER– (BUSINESS WIRE)...

H.I.G. Capital Acquires DGS S.p.A.

The investment will support the further growth of DGS Group, a leading Italian information technology specialist MILAN–(BUSINESS WIRE)– H.I.G. Europe (“H.I.G.”), the European affiliate of...

Boehringer Ingelheim and Click Therapeutics Enter into Collaboration to Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia

This collaboration combines Click Therapeutics’ specialty in developing efficacious and engaging digital therapeutics with Boehringer Ingelheim’s expertise in clinical development of treatments for neuropsychiatric diseases,...

Mundipharma Ranked One of the 2020 Best Workplaces in Europe by Great Place to Work®

CAMBRIDGE, England–(BUSINESS WIRE)– Mundipharma is delighted to announce that Great Place to Work® – the global authority on workplace culture – has named it as...

Aegon Bank publishes first half 2020 report

THE HAGUE, Netherlands–(BUSINESS WIRE)– Aegon Bank N.V. has published its first half 2020 report, which describes how the company has performed and contains interim financial...

Elliott Statement on Aryzta AG

LONDON–(BUSINESS WIRE)– Elliott Advisors (UK) Limited confirms that it today has submitted a letter to Aryzta AG’s Board in relation to advanced discussions regarding an...

Vedacit Boosts Innovation With Savings From Switching Its Oracle JD Edwards and Database Software to Rimini Street Support

Brazilian construction products manufacturer diverts support savings to help fund product development startups aimed at creating patented innovations and growing revenue LAS VEGAS–(BUSINESS WIRE)– Rimini...

Clovis Oncology Announces Oral Plenary Session Presentation at International Gynecologic Cancer Society (IGCS) Digital Annual Global Meeting

Accepted abstract describes exploratory analysis from ARIEL3 further suggesting the durable clinical benefit of Rubraca maintenance treatment beyond progression for women with platinum-sensitive recurrent ovarian...